CClinicalTrials.gg
Status unknownNCT05325255Updated Feb 16, 2023

Effect of Myofascial Release of Subscapularis Along With Shoulder Mobilization in Adhesive Capsulitis

An interventional study of Myofascial release of subscapularis and Maitland mobilization in Adhesive Capsulitis of Shoulder, sponsored by Dow University of Health Sciences. Status unknown at 2 sites in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-02-16.

Sponsored by Dow University of Health Sciences · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This randomized control trial aims to compare the effect of myofascial release of subscapularis along with shoulder mobilization VS mobilization alone among patients with adhesive capsulitis. The study will be conducted at physiotherapy outpatient department (OPD) of Sindh Institute of physical medicine and rehabilitation, and Dow University Ojha Campus, Karachi. According to study criteria, 70 patients with sub-acute adhesive capsulitis will be selected through a non-randomized purposive sampling technique by a consultant physician. After taking informed consent, participants will be randomly divided into 2 groups through the sealed envelope method. Both the groups will receive conventional treatment while Group 1 will be given an additional treatment of myofascial release of subscapularis through ischemic compression technique. Total 6 treatment sessions will be provided and assessment will be done at baseline and end of the 6th session.

Read the detailed description

The sample size of 31 per group was determined using planning and specification software (PASS) version 15 software based on two independent sample t-test using 95%confidence interval and 80% power of the test. This sample was raised to 35 per group with 4 patients as drop out per group. Mean and standard deviation will be calculated for the quantitative variables while frequency and percentages will be calculated for qualitative variables. Inter-group comparison at baseline will be calculated using an independent sample t-test. The mean difference between both the techniques in terms of numeric pain rating scale (NPRS), range of motion (ROM), shoulder pain and disability index (SPADI), and pain pressure threshold(PPT) will be determined using Repeated measure 2-way ANOVA.

02

Conditions studied

  • Adhesive Capsulitis of Shoulder

Browse trials for

Keywords

  • Adhesive capsulitis
  • Muscle stretching exercise
  • Myofascial trigger point
  • Range of motion
  • Pain
03

In context

Bursitis

411 studies on the registry are indexed under Bursitis; 112 are open to participants now.

This study's planned enrollment of 70 is above the median of 45 across 371 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Dow University of Health Sciences is the lead sponsor of 170 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged between 40-65 years
  • Diagnosed with sub-acute adhesive capsulitis
  • Pain range of 3 to 8 on NPRS
  • SPADI score of >40
  • Presence of myofascial trigger point in subscapularis muscle

Exclusion criteria

Exclusion Criteria:

  • History of fracture
  • Rheumatoid arthritis
  • Shoulder osteoarthritis
  • Any malignancy
  • Shoulder dislocation
  • Subacute adhesive capsulitis with impingement syndrome
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Maitland mobilization with myofascial trigger point release group

    Maitland technique: caudal, anteroposterior (AP), and posteroanterior (PA) glides 5 sets of 2-3 glides per second of Grade III and IV for 30 seconds with a rest interval of 30 second between sets. Ischemic Compression technique: on subscapularis trigger points for 90 secs thrice a week for 2 weeks. Stretching exercises in direction of abduction, external rotation (ER), internal rotation (IR), and flexion. 6 repetitions of each stretch for 10 seconds Cold pack for 20 mins

    Other: Myofascial release of subscapularis · Other: Maitland mobilization · Other: Stretching exercises · Other: Cold pack

  • Active comparator
    Maitland mobilization alone group

    Maitland technique: caudal, anteroposterior (AP), and posteroanterior (PA) glides 5 sets of 2-3 glides per second of Grade III and IV for 30 seconds with a rest interval of 30 second between sets. Stretching exercises in direction of abduction, external rotation (ER), internal rotation (IR), and flexion. 6 repetitions of each stretch for 10 seconds Cold pack for 20 mins

    Other: Maitland mobilization · Other: Stretching exercises · Other: Cold pack

Interventions

  • OtherMyofascial release of subscapularis

    It is the application of manual pressure over myofascial trigger point that induces ischemia and causes release of trigger points

  • OtherMaitland mobilization

    It is the type of mobilization technique that uses passive accessory mobilization to reduce pain and stiffness and increasing range of motion

  • OtherStretching exercises

    It is the technique use to increase flexibility and range of motion of short and hypomobile structures

  • OtherCold pack

    It is the application of cold to provide analgesic effects

06

What researchers measure

Primary outcomes

  1. Change from baseline pain intensity on Numeric Pain Rating Scale in scores at 6th session (10 days)

    It will be use to assess pain intensity. It will be administered by simply asking the intensity of pain experienced in last 24 hours. The response of 0 represent no pain rather the responses between 1-3, 4-6, and 7-9 represents mild, moderate, and severe pain respectively. While 10 is the worst possible pain ever experienced by the person

    Time frame: At baseline and after 6 sessions (10 days)

  2. Change from baseline joint range of motion on universal goniometer in degrees at 6th session (10 days)

    It will be assessed by using standard universal goniometer and measured in degrees

    Time frame: At baseline and after 6 sessions (10 days)

  3. change from baseline shoulder disability on Shoulder pain and disability index in percentage at 6th session (10 days)

    Shoulder pain and disability index is used to assess shoulder disability. It consist of 13 questions i .e. 5 to assess pain and 8 to assess disability. Results will be calculated in percentage and higher results indicate increased disability. lower the percentage better will be the outcome.

    Time frame: At baseline and after 6 sessions (10 days)

  4. Change from baseline pain pressure threshold on algometer in kilogram/centimeter2 at 6th session (10 days)

    assessed through algometer which provide sustained pressure from 0.05Newton/second to 20 Newton/second. Results will be recorded in kilogram/centimeter2 and higher values indicate decrease sensitivity of myofascial trigger points

    Time frame: At baseline and after 6 sessions (10 days)

07

Study locations

2 of 2 sites recruiting
  • Sindh Institute Physical Medicine and Rehabilitation
    Karachi, Sindh 74200, Pakistan
    • Aftab Ahmed Mirza Baig, MSAPT · Contact · ab.dptrm@gmail.com · +923002739920
    • Umama Abbasi, DPT · Principal investigator
    Recruiting
  • Dow University Hospital Ojha Campus
    Karachi, Sindh, Pakistan
    • Umama Abbasi, PG student · Contact · umamaabbasi42@gmail.com · +923122930340
    • Umama Abbasi, DPT · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05325255
Lead sponsor
Dow University of Health Sciences
Responsible party
Umama Abbasi (Principle Investigator, Dow University of Health Sciences) — Principal investigator
First posted
Apr 13, 2022
Start date
Apr 26, 2022
Primary completion
Apr 30, 2023 (estimated)
Completion
Apr 30, 2023 (estimated)
Last update
Feb 16, 2023

Study contacts

Umama Abbasi, DPT
Contact
umamaabbasi42@gmail.com
+923122930340
Aftab Ahmed Mirza Baig, MSAPT
Contact
ab.dptrm@gmail.com
+923002739920
Umama Abbasi, DPT
principal investigator · Dow University of Health Sciences
Rabail R Soomro, PhD Scholar
study director · Sindh Institute of Physical Medicine and Rehabilitation
Aftab Ahmed Mirza Baig, MSAPT
study director · Sindh Institute of Physical Medicine and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion